about
A new HCV mouse model on the block.Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibodyGeneration of an adenovirus-parvovirus chimera with enhanced oncolytic potential.A novel adenovirus vector for easy cloning in the E3 region downstream of the CMV promoterGenetically engineered T-cells expressing a ganciclovir-sensitive HSV-tk suicide gene for the prevention of GvHD.Hepatitis C virus infection and related liver disease: the quest for the best animal modelArtificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells.Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector.Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21.Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies.Genetically humanized mice recapitulate the entire hepatitis C virus life cycle.Toward novel immunocompetent animal models for hepatitis B virus infection.[Locked outside: cure of chronic hepatitis C using an entry inhibitor].
P50
Q34289919-0CA8A09D-CEAE-4730-8ED4-5437ACDBBCF3Q35135565-CB9215E2-9C7F-4696-A4DE-65C8DE62A249Q35602284-5C21BDB4-7763-4F6B-A19A-8FFFCB6E74EDQ36276709-98993B12-96EE-461E-8C4A-BEA298E4E1F3Q36718570-FD156ED2-2150-4220-8A87-10E208EDF1E8Q37737174-3B96BB1D-2613-4257-A26F-22FF4624BA4BQ38125192-54E8F973-6936-4B0B-A199-5EC899E18FB4Q38846425-8D3DAE6E-2519-48B8-AB42-8B9678380B92Q38996776-E126553A-8D5E-44A0-8A6E-055634C6F63AQ40101558-9CA32A45-76FD-418E-ADDB-98657CBFFF68Q40122305-F32EBA3A-6A6D-4426-9B0C-07CAB9CEBFADQ40271516-BAAD4422-A683-478E-A03E-D25A9DE26079Q40273729-DF538958-C2E8-42EC-90D6-E4C3C739C6CFQ40581806-BEA6EC9E-0C55-4EB1-99BF-EF24C80760BEQ42262306-4563B5B2-F0E1-4F2A-A625-885D0600707EQ45329084-35F9100E-D18A-4009-B6A5-2DE232F31DBFQ54702553-E9BD34C8-9C76-447B-8776-9C2ED9160514
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laurent Mailly
@ast
Laurent Mailly
@en
Laurent Mailly
@es
Laurent Mailly
@nl
type
label
Laurent Mailly
@ast
Laurent Mailly
@en
Laurent Mailly
@es
Laurent Mailly
@nl
prefLabel
Laurent Mailly
@ast
Laurent Mailly
@en
Laurent Mailly
@es
Laurent Mailly
@nl
P106
P31
P496
0000-0001-6957-7463